Targeted therapies and thyroid cancer: an update

被引：5
|
作者：
de la Fouchardiere, Christelle [1 ]
Droz, Jean-Pierre [1 ]
机构：
[1] Univ Lyon 1, Ctr Leon Berard, F-69008 Lyon, France
来源：
ANTI-CANCER DRUGS | 2011年 / 22卷 / 07期
关键词：
anaplastic thyroid carcinoma; differentiated thyroid carcinoma; medullary thyroid carcinoma; targeted therapy; PHASE-II TRIAL; TYROSINE KINASE INHIBITORS; ADVANCED MEDULLARY; ALTERNATING COMBINATION; PROGNOSTIC-FACTORS; CARCINOMA; SORAFENIB; SUNITINIB; EFFICACY; GROWTH;
D O I：
10.1097/CAD.0b013e32834319c7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The treatment of metastatic, progressive thyroid cancer has evolved over recent years. New 'targeted' therapeutic approaches have been developed along with advances in the knowledge of thyroid carcinogenesis and the identification of tumor and endothelial targets. In recent years, results of targeted therapies have shown some benefit in refractory, progressive, differentiated, and medullary thyroid carcinomas but not, until recently, in undifferentiated thyroid carcinoma. We review here the different targeted therapies tested in thyroid cancers. Anti-Cancer Drugs 22: 688-699 (C) 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins.
引用
收藏
页码：688 / 699
页数：12
相关论文
共 50 条
  • [31] Molecular basis and targeted therapies for radioiodine refractory thyroid cancer
    Yu, Qiuxiao
    Zhang, Xuwen
    Li, Li
    Zhang, Chi
    Huang, Jian
    Huang, Wenting
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 (03) : 279 - 289
  • [32] The Treatment of Advanced Thyroid Cancer in the Age of Novel Targeted Therapies
    Lirov, Roy
    Worden, Francis P.
    Cohen, Mark S.
    DRUGS, 2017, 77 (07) : 733 - 745
  • [33] Treatment of advanced thyroid cancer: role of molecularly targeted therapies
    Covell, Lorinda L.
    Ganti, Apar Kishor
    TARGETED ONCOLOGY, 2015, 10 (03) : 311 - 324
  • [34] Novel in vitro targeted combination therapies for anaplastic thyroid cancer
    Kunnimalaiyaan, Muthusamy
    Parekh, Parag
    Golden, Jalyn
    Anderson, Ying
    Lai, Stephen
    Cabanillas, Maria
    Zafereo, Marc
    Dadu, Ramona
    Hofmann, Marie-Claude
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [35] Treatment of advanced thyroid cancer: role of molecularly targeted therapies
    Lorinda L. Covell
    Apar Kishor Ganti
    Targeted Oncology, 2015, 10 : 311 - 324
  • [36] Dedifferentiated thyroid cancer, molecular markers and new targeted therapies
    Antonelli, Alessandro
    Fallahi, Poupak
    Ferrari, Silvia Martina
    Carpi, Angelo
    Berti, Piero
    Materazzi, Gabriele
    Minuto, Michele
    Guastalli, Mario
    Miccoli, Paolo
    BIOMEDICINE & PHARMACOTHERAPY, 2008, 62 (08) : 521 - 521
  • [37] Advances in the treatment of thyroid cancer in the era of molecularly targeted therapies
    Malouf, G.
    Baudin, E.
    Soria, J. -C.
    Schlumberger, M.
    BULLETIN DU CANCER, 2009, 96 (01) : 95 - 101
  • [38] Advances in Biomarker-Driven Targeted Therapies in Thyroid Cancer
    Mishra, Prachi
    Laha, Dipranjan
    Grant, Robert
    Nilubol, Naris
    CANCERS, 2021, 13 (24)
  • [39] The Treatment of Advanced Thyroid Cancer in the Age of Novel Targeted Therapies
    Roy Lirov
    Francis P. Worden
    Mark S. Cohen
    Drugs, 2017, 77 : 733 - 745
  • [40] Targeted therapies for thyroid tumors
    Sherman, Steven I.
    MODERN PATHOLOGY, 2011, 24 : S44 - S52
12345